Insulin Resistance: Signs, Tests, and How to Actually Fix It

Insulin resistance is the metabolic thread connecting obesity, type 2 diabetes, PCOS, fatty liver disease, cardiovascular disease, and certain cancers. It's not a disease itself — it's a dysfunction that precedes and drives multiple diseases.

About 40% of American adults have insulin resistance to some degree. Most have no idea.

What Insulin Resistance Actually Is

When you eat carbohydrates, blood glucose rises. Your pancreas secretes insulin to manage it — insulin signals cells (muscle, liver, fat tissue) to take up glucose from the blood. In a healthy metabolic state, a modest insulin response efficiently clears glucose.

In insulin resistance, cells stop responding normally to insulin signals. The pancreas compensates by producing more insulin. Blood glucose normalizes, but at the cost of chronically elevated insulin — hyperinsulinemia.

Hyperinsulinemia has broad downstream effects: - Fat storage acceleration — insulin is the primary fat-storage hormone; elevated baseline insulin means persistent fat storage signal - Fat release suppression — you can't effectively burn stored fat when insulin is elevated - Ovarian androgen stimulation — relevant in PCOS - Vascular inflammation — elevated insulin promotes atherosclerosis - Pancreatic strain — years of compensation eventually exhaust beta cells, leading to type 2 diabetes

This is why weight loss is so difficult for insulin-resistant individuals. The metabolic environment is biochemically tilted toward fat storage.

The Spectrum: Pre-Diabetes to Type 2

Insulin resistance exists on a spectrum:

Stage 1 — Insulin resistance, normal glucose: Fasting glucose is normal (<100 mg/dL), but fasting insulin is elevated (>10 µIU/mL). HOMA-IR is elevated. This is fully reversible.

Stage 2 — Pre-diabetes: Fasting glucose 100-125 mg/dL, or HbA1c 5.7-6.4%, or 2-hour glucose on OGTT 140-199 mg/dL. Still largely reversible with intervention. About 88 million American adults are here.

Stage 3 — Type 2 diabetes: Fasting glucose ≥126 mg/dL, HbA1c ≥6.5%, or 2-hour OGTT ≥200 mg/dL. Management rather than simple reversal, though significant improvement is still achievable.

Signs You Might Have It

Insulin resistance often has no symptoms in early stages — it progresses silently. But patterns that should prompt investigation:

Metabolic: - Central adiposity ("apple shape" — fat accumulation around the abdomen and organs despite normal overall BMI in some cases) - Inability to lose weight despite reasonable effort and caloric restriction - Post-meal fatigue or drowsiness ("food coma") - Strong cravings for carbohydrates, especially 2-3 hours after eating

Physical: - Acanthosis nigricans — velvety dark patches in skin folds (neck, armpits, groin). This is a dermatological manifestation of hyperinsulinemia and is highly specific. - Skin tags — benign but associated with insulin resistance - Polycystic ovaries / PCOS in women

Labs: - Fasting glucose 95-125 mg/dL - Triglycerides >150 mg/dL - HDL <40 (men) or <50 (women) - High blood pressure (≥130/85) - HbA1c 5.5-6.4%

Having three or more metabolic lab findings constitutes metabolic syndrome — essentially a clinical diagnosis of insulin resistance with cardiovascular risk.

How to Actually Test for It

Standard metabolic panels miss insulin resistance in the early, reversible stages. Here's what to ask for:

Most useful tests: 1. Fasting insulin — most labs set normal as <25 µIU/mL, but metabolically optimal is <10 µIU/mL. Elevated fasting insulin with normal glucose = early insulin resistance. 2. HOMA-IR = (fasting insulin × fasting glucose) / 405. Above 2.0 suggests insulin resistance; above 2.5 is more definitive. 3. Fasting triglycerides — a simple, cheap proxy. Triglycerides >150 mg/dL in a fasting state is a reasonable indicator. 4. 2-hour oral glucose tolerance test (OGTT) — the gold standard diagnostic for pre-diabetes and insulin resistance pattern

Most primary care panels include fasting glucose and HbA1c but skip fasting insulin. Asking specifically for fasting insulin significantly improves early detection.

Lifestyle Interventions — What Actually Moves the Needle

1. Reduce processed carbohydrates (especially refined/liquid) Not zero carbs — but targeting refined grains, sugary beverages, and ultra-processed foods dramatically reduces the glucose/insulin response load. The glycemic index/load framework is useful: prioritize low-glycemic carbohydrates (legumes, whole grains, vegetables) over high-glycemic ones.

2. Resistance training — the most underrated intervention Skeletal muscle is the primary glucose sink in the body. More muscle = more capacity to clear glucose without insulin. Resistance training also improves insulin sensitivity in muscle cells independent of weight loss through GLUT4 translocation. 3x/week progressively loaded resistance training is more impactful than equivalent time on cardio for insulin resistance reversal.

3. Aerobic exercise (secondary but complementary) Zone 2 cardio improves mitochondrial function and insulin sensitivity, particularly in metabolically active tissues. 150+ minutes per week.

4. Time-restricted eating / intermittent fasting Extending overnight fasting to 14-16 hours gives insulin a prolonged low period, which over time helps restore sensitivity. Not magic — but the mechanism is real.

5. Weight loss itself Even modest weight loss (5-10% of body weight) produces significant insulin sensitivity improvement. The direction of causation runs both ways: improving insulin sensitivity makes weight loss easier, and weight loss improves insulin sensitivity.

Medications

Metformin First-line pharmaceutical treatment for insulin resistance and pre-diabetes. Mechanism: primarily reduces hepatic glucose output and modestly improves peripheral insulin sensitivity. Well-tolerated, cheap, 60+ years of safety data. Standard starting dose 500mg twice daily with meals. Main side effect: GI upset, particularly in the first weeks.

GLP-1 Agonists (Semaglutide, Tirzepatide) Most powerful currently available intervention for insulin resistance combined with weight loss. Tirzepatide's dual GIP/GLP-1 mechanism is particularly potent for insulin sensitization. The magnitude of improvement in HOMA-IR from GLP-1 therapy typically exceeds metformin. Higher cost, but the metabolic results are substantially better.

SGLT-2 Inhibitors (Empagliflozin, Dapagliflozin) Originally diabetes medications, now showing benefit in pre-diabetes and heart failure prevention. Mechanism: cause kidneys to excrete excess glucose in urine, reducing glucose load. Strong cardiovascular and renal protective effects.

Berberine An OTC plant alkaloid with metformin-like AMPK activation mechanism. Multiple RCTs show glucose and insulin-sensitizing effects comparable to low-dose metformin. Not as powerful as pharmaceutical options, but legitimate mechanism — unlike most supplements. 500mg 2-3x daily with meals.

The Practical Protocol

If you suspect insulin resistance: 1. Get labs: fasting glucose, fasting insulin (calculate HOMA-IR), HbA1c, fasting lipids 2. If HOMA-IR >2.0: treat with aggressive lifestyle first — resistance training 3x/week, reduce refined carbs, lose 5-10% body weight 3. If lifestyle is insufficient or HOMA-IR >3.0: consider metformin with physician guidance 4. If significant weight loss is needed and lifestyle hasn't achieved it: GLP-1 therapy is the most powerful tool currently available

Insulin resistance caught in Stage 1 is fully reversible. Caught at Stage 2 (pre-diabetes), it's largely reversible. Don't wait for the Stage 3 diagnosis.

[Start a metabolic consultation at Marrow](/start) — physician review in 24 hours.